alprenolol and digoxin

alprenolol has been researched along with digoxin in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (25.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (50.00)	29.6817
2010's	2 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P	1
Artursson, P; Bergström, CA; Matsson, P; Nagahara, N; Norinder, U; Tavelin, S	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K	1
Ekelund, LG; Johnsson, G; Melcher, A; Orö, L	1
Pedersen, F; Rasmussen, SL	1

Trials

2 trial(s) available for alprenolol and digoxin

Article	Year
Effects of cedilanid-D and alprenolol in angina pectoris. European journal of clinical pharmacology, 1973, Volume: 6, Issue:2 Topics: Alprenolol; Angina Pectoris; Blood Pressure; Cardiac Output; Cardiac Volume; Digoxin; Electrocardiography; Exercise Test; Female; Heart Ventricles; Hemodynamics; Humans; Lanatosides; Male; Middle Aged; Physical Exertion; Placebos; Time Factors	1973
Short-term and long-term tolerance to beta-blockade with alprenolol in patients admitted for a suspected acute myocardial infarction. Acta medica Scandinavica. Supplementum, 1984, Volume: 680 Topics: Administration, Oral; Aged; Alprenolol; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Digoxin; Diuretics; Drug Therapy, Combination; Heart Failure; Heart Rate; Humans; Injections, Intravenous; Middle Aged; Myocardial Infarction; Random Allocation; Time Factors	1984

Article

Year

Effects of cedilanid-D and alprenolol in angina pectoris.

European journal of clinical pharmacology, 1973, Volume: 6, Issue:2

Topics: Alprenolol; Angina Pectoris; Blood Pressure; Cardiac Output; Cardiac Volume; Digoxin; Electrocardiography; Exercise Test; Female; Heart Ventricles; Hemodynamics; Humans; Lanatosides; Male; Middle Aged; Physical Exertion; Placebos; Time Factors

1973

Short-term and long-term tolerance to beta-blockade with alprenolol in patients admitted for a suspected acute myocardial infarction.

Acta medica Scandinavica. Supplementum, 1984, Volume: 680

Topics: Administration, Oral; Aged; Alprenolol; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Digoxin; Diuretics; Drug Therapy, Combination; Heart Failure; Heart Rate; Humans; Injections, Intravenous; Middle Aged; Myocardial Infarction; Random Allocation; Time Factors

1984

Other Studies

6 other study(ies) available for alprenolol and digoxin

Article	Year
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability. Journal of medicinal chemistry, 2004, Mar-25, Volume: 47, Issue:7 Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties	2004
Exploring the role of different drug transport routes in permeability screening. Journal of medicinal chemistry, 2005, Jan-27, Volume: 48, Issue:2 Topics: Administration, Oral; Biological Transport; Caco-2 Cells; Cell Line; Humans; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Membranes, Artificial; Models, Biological; Molecular Conformation; Monte Carlo Method; Permeability; Pharmaceutical Preparations; Pharmacokinetics	2005
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
QSAR-based permeability model for drug-like compounds. Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8 Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2011